[ 3 / biz / cgl / ck / diy / fa / ic / jp / lit / sci / vr / vt ] [ index / top / reports ] [ become a patron ] [ status ]
2023-11: Warosu is now out of extended maintenance.

/biz/ - Business & Finance

Search:


View post   

>> No.13533791 [View]
File: 333 KB, 1105x1396, tax-us-vs-oecd.jpg [View same] [iqdb] [saucenao] [google]
13533791

>>13533744
>cumulatively make your money back in 15 years doing absolutely nothing and/or be able to save up enough money to start a risk-free business almost immediately

or

>invest in a two time Russian crypto exit-scammer who doesn't code and whose sole accomplishment is his philosophy degree

stay poor bag-fag

>> No.12916523 [View]
File: 333 KB, 1105x1396, tax-us-vs-oecd.jpg [View same] [iqdb] [saucenao] [google]
12916523

>>12915986
>This is fundamentally what for profit healthcare looks like.

EU countries' healthcare systems are operated for-profit too, their income streams just come in the form of individual income tax rates you'd expect of a group of nations that have been in a constant state of total war for the past 70 years instead of the little inconsequential overcrowded Wisconsins they really are, and this is all despite opportunistically relying on American pharmaceutical R&D as it is.

>Up until three months ago we couldn't even see what our competitors were charging nor they us.

Competition-friendly transparency is a good thing, it's why the Playstation 4 cost $100 less than the Xbox One at launch.

>Sounds like we Amerifats should act more like Europeans on this one. Seems to be working well for them.

Considering that, once again, we are responsible for the lion's share of drug research that takes place across the entire planet by a large margin, saying we should do "what they do" doesn't make a lot of sense. Are these drugs better off undeveloped?

>If U.S. companies earned more revenue from foreign nations, then the American companies could spend more on R&D. This ultimately would result in new treatments and inject more competition into the U.S. drug market, leading to lower prices for American patients.

>Just consider what happened with the numerous next-generation hepatitis C medicines released in recent years. These revolutionary drugs have been shown to cure 70-99% of patients. The first medicine gained FDA approval in late 2013 and debuted with a list price of $84,000 for a full course of treatment. Over the next four years, several competing drugs flooded the market.

>Prices subsequently dropped about 70% a few years later, as manufacturers heavily discounted their cures to win market share.

http://fortune.com/2018/08/09/trump-drugs-prices-pharmaceutical-research/

>> No.12823206 [View]
File: 333 KB, 1105x1396, tax-us-vs-oecd.jpg [View same] [iqdb] [saucenao] [google]
12823206

>>12822690
The corporate tax rate here was much higher than it was in "Communist" China until now, and higher than most other developed countries for many years as well.

Navigation
View posts[+24][+48][+96]